Isosorbide Dinitrate And Hydralazine Hydrochloride Tablet
Product Images NDC 50742-246

9 FDA label images from Ingenus Pharmaceuticals, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Isosorbide Dinitrate And Hydralazine Hydrochloride (NDC 50742-246). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ingenus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (128d934d 8313 4fc7 94af 1a2451d6f019 01)

Image (128d934d 8313 4fc7 94af 1a2451d6f019 01)
Chemical structure diagram of isosorbide dinitrate, part of the combination in Isosorbide dinitrate and hydralazine hydrochloride tablets. The structure shows a bicyclic compound with two nitrate groups attached.*
FDA Label Image

Image (128d934d 8313 4fc7 94af 1a2451d6f019 02)

Image (128d934d 8313 4fc7 94af 1a2451d6f019 02)
Chemical structure of isosorbide dinitrate and hydralazine hydrochloride. The diagram shows the molecular configuration with nitrogen-containing rings and labeling for HCl, indicating the hydrochloride component.*
FDA Label Image

Image (128d934d 8313 4fc7 94af 1a2451d6f019 03)

Image (128d934d 8313 4fc7 94af 1a2451d6f019 03)
A Kaplan-Meier plot showing time to death by all causes in Black patients, comparing Isosorbide Dinitrate and Hydralazine Hydrochloride Tablets with placebo over approximately 600 days. The solid line represents the tablets, the dashed line represents placebo, showing a 43% reduction in mortality with the tablets. The graph includes a p-value of 0.012 from a log-rank test and sample sizes at various time points for each group.*
FDA Label Image

Image (128d934d 8313 4fc7 94af 1a2451d6f019 04)

Image (128d934d 8313 4fc7 94af 1a2451d6f019 04)
A Kaplan-Meier plot showing time to first hospitalization for heart failure in Black patients treated with Isosorbide Dinitrate and Hydralazine Hydrochloride Tablets versus placebo. The plot displays percent without hospitalization on the y-axis and time in days on the x-axis, illustrating a 39% risk reduction in hospitalization for the treatment group compared to placebo.*
FDA Label Image

Image (128d934d 8313 4fc7 94af 1a2451d6f019 05)

Image (128d934d 8313 4fc7 94af 1a2451d6f019 05)
A bar graph titled 'Change in Minnesota Living With Heart Failure Score' comparing Isosorbide Dinitrate and Hydralazine Hydrochloride Tablets versus placebo over 18 months. The y-axis shows change in score (improvement downward), and the x-axis shows time points in months. Striped bars represent the drug group, solid black bars represent placebo. Numeric values below indicate sample sizes at each time point for both groups. Statistical significance is indicated with asterisks for P values below 0.05 and 0.01.*
FDA Label Image

Image (128d934d 8313 4fc7 94af 1a2451d6f019 06)

Image (128d934d 8313 4fc7 94af 1a2451d6f019 06)
A forest plot chart illustrating the results for demographic, baseline medication, and clinical characteristic subgroups in Black patients from the A-HeFT study. The chart compares all-cause mortality and first hospitalization for heart failure between patients treated with Isosorbide Dinitrate and Hydralazine Hydrochloride tablets versus placebo, showing relative risk with 95% confidence intervals across various subgroups such as age, gender, hypertension history, diabetes, and medication use.*
FDA Label Image

Image (128d934d 8313 4fc7 94af 1a2451d6f019 07)

FDA Label Image

Bottle Label (128d934d 8313 4fc7 94af 1a2451d6f019 08)

Bottle Label (128d934d 8313 4fc7 94af 1a2451d6f019 08)
Label for Isosorbide Dinitrate and Hydralazine Hydrochloride Tablets, 20 mg/37.5 mg strength, oral tablets. Pack contains 180 tablets. Manufactured for Ingenus Pharmaceuticals, LLC, Orlando, FL. Includes NDC 50742-246-18 and storage instructions.*
FDA Label Image

Bottle Label 90ct (128d934d 8313 4fc7 94af 1a2451d6f019 09)

Bottle Label 90ct (128d934d 8313 4fc7 94af 1a2451d6f019 09)
Label for Isosorbide Dinitrate and Hydralazine Hydrochloride Tablets, 20 mg/37.5 mg strength, oral tablets. The package contains 90 tablets. Manufactured for Ingenus Pharmaceuticals, LLC, Orlando, FL. Includes storage instructions and a barcode, with a note about no varnish 1.75" x 1".*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.